Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hemolytic anemia epidemiology and demographics
Introduction
Overview
Overview
In general, hemolytic anemia is a relatively rare condition. The incidence and prevalence are fairly low.
Epidemiology and Demographics
Epidemiology and Demographics
- Worldwide, the incidence of autoimmune hemolytic anemia is 0.8 per 100,000 persons.[1] Some studies suggest that the incidence of autoimmune hemolytic anemia in adults in 1:100,000 persons.[2] The incidence of hemolytic anemia is lower in children.
- Worldwide, the prevalence of autoimmune hemolytic anemia is 17 per 100,000 persons.[1]
- Worldwide, the incidence of drug-induced hemolytic anemia is 0.1 per 100,000 persons.[3]
Gender
- Hemolytic anemia affects men and women equally.
Race
- Hemolytic anemia affects all races equally.
Age
- Hemolytic anemia affects adults more commonly than children.[2]
References
References
- ↑ 1.0 1.1 Baek SW, Lee MW, Ryu HW, Lee KS, Song IC, Lee HJ; et al. (2011). “Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases”. Korean J Hematol. 46 (2): 111–7. doi:10.5045/kjh.2011.46.2.111. PMC 3128891. PMID 21747883.
- ↑ 2.0 2.1 Berentsen S, Sundic T (2015). “Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy”. Biomed Res Int. 2015: 363278. doi:10.1155/2015/363278. PMC 4326213. PMID 25705656.
- ↑ Packman CH (2015). “The Clinical Pictures of Autoimmune Hemolytic Anemia”. Transfus Med Hemother. 42 (5): 317–24. doi:10.1159/000440656. PMC 4678314. PMID 26696800.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Shyam Patel [2]